Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457190) titled 'Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Beijing Union Pharmaceutical Factory Ltd

Condition: Generalized Anxiety Disorder

Intervention: Drug: Buagafuran

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 2026

Target Sample Size: 24

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/s...